Specimen validity testing determines if the specimens have been adulterated with an agent or substance, or if they have been substituted with a non-urine fluid.
Once a urine specimen is received in one of our labs, it is scanned into the system and receives a unique lab accession number of the most reliable identification and tracking. Then, an alliquoted sample undergoes validity testing (as a part of initial testing) using PH values, specific gravity and creatinine to ensure it is a human sample and that it has not been diluted or adulterated. Along with this, the urine sample will be screened for the presence or absence of benzodiazepines, opiates, and other illicit drugs using Diatron P500.
Amphetamine, Barbiturates, Benzodiazepines, Buprenorphine, Cannabinoid, Cocaine, Ethyl Alcohol, Methadone, MDMA, Oplates, Oxycodone, PCP, TCA-impipramine
Liquid chromatography - tandem mass spectrometry (LC/MS/MS) is used when optimal specificity and sensitivity are required to determine the absence or presence of your patients prescribed medications as well as the presence of non-prescribed medications or illicits.
81161, 81405, 81406, 81407, 81439
NOTE: The CPT codes listed on the website are in accordance with Current Procedural Terminology, a publication of the American Medical Association. CPT codes are provided here for the convenience of our clients. Clients who bill for services should make the final decision on which codes to use.
99.0% of targeted genomic regions at 20X coverage or higher
Beckmann, B.M., Pfeufer, A., & Kääb, S. Inherited cardiac arrhythmias: diagnosis, treatment, and prevention. Dtsch Arztebl Int. 2011 Sep;108(37):623-33 (2011) Kimura, A. Molecular genetics and pathogenesis of cardiomyopathy. J Hum Genet. Jan;61(1):41-50 (2016)